Form 8-K - Current report:
SEC Accession No. 0000950123-09-003574
Filing Date
2009-02-26
Accepted
2009-02-26 17:09:52
Documents
1
Period of Report
2009-02-23
Items
Item 4.02: Non-Reliance on Previously Issued Financial Statements or a Related Audit Report or Completed Interim Review

Document Format Files

Seq Description Document Type Size
1 FORM 8-K y01218e8vk.htm 8-K 24530
  Complete submission text file 0000950123-09-003574.txt   26313
Mailing Address 2 SNUNIT ST SCIENCE PARK, POB 455 CARMIEL L3 20100
Business Address 2 SNUNIT ST SCIENCE PARK, POB 455 CARMIEL L3 20100 972-4-988-9488
Protalix BioTherapeutics, Inc. (Filer) CIK: 0001006281 (see all company filings)

EIN.: 650643773 | State of Incorp.: FL | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-33357 | Film No.: 09638580
SIC: 2836 Biological Products, (No Diagnostic Substances)